Use of angiotensin II inhibitors in patients that develop encapsulating peritoneal sclerosis

Peritoneal Dialysis International

Volumn 30, Issue 6, 2010, Pages 656-659

  Sampimon, Denise E ^a   Kolesnyk, Inna ^a   Korte, Mario R ^b   Fieren, Marien W J A ^c   Struijk, Dirk G ^a,d   Krediet, Raymond T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ALBERT SCHWEITZER HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d Dianet Foundation   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ADULT; AGED; APPENDECTOMY; ARTICLE; ASCITES; AUTOPSY; CATHETERIZATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; INTESTINE OBSTRUCTION; INTESTINE SURGERY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LAPAROTOMY; MALE; NETHERLANDS; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RELAPSE; RISK FACTOR; SCHOOL CHILD; TREATMENT DURATION; UMBILICAL HERNIA;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; APPENDECTOMY; CASE-CONTROL STUDIES; CATHETERS, INDWELLING; CAUSE OF DEATH; CHILD; FASCIA; FEMALE; FOLLOW-UP STUDIES; HERNIA, UMBILICAL; HUMANS; KIDNEY TRANSPLANTATION; LAPAROTOMY; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONEUM; PERITONITIS; RENAL DIALYSIS; TISSUE ADHESIONS; VASOCONSTRICTOR AGENTS; YOUNG ADULT;

EID: 78650102593     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2009.00201     Document Type: Article

References (11)

1. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000; 20(Suppl 4):S43-55.
2. Hendriks PM, Ho-dac-Pannekeet MM, van Gulik TM, Struijk DG, Phoa SS, Sie L, et al. Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics. Perit Dial Int 1997; 17:136-43.
3. Mateijsen MA, van der Wal AC, Hendriks PM, Zweers MM, Mulder J, Struijk DG, et al. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 1999; 19:517-25.
4. Noh H, Ha H, Yu MR, Kim YO, Kim JH, Lee HB. Angiotensin II mediates high glucose-induced TGF-beta1 and fibronectin upregulation in HPMC through reactive oxygen species. Perit Dial Int 2005; 25:38-47.
5. Duman S, Gunal AI, Sen S, Asci G, Ozkahya M, Terzioglu E, et al. Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution? Perit Dial Int 2001; 21:219-24.
6. Sawada T, Ishii Y, Tojimbara T, Nakajima I, Fuchinoue S, Teraoka S. The ACE inhibitor, quinapril, ameliorates peritoneal fibrosis in an encapsulating peritoneal sclerosis model in mice. Pharmacol Res 2002; 46:505-10.
7. Fieren MW, Betjes MG, Korte MR, Boer WH. Posttransplant encapsulating peritoneal sclerosis: a worrying new trend? Perit Dial Int 2007; 27:619-24.
8. Summers AM, Brenchley PE. An international encapsulating peritoneal sclerosis registry and DNA bank: why we need one now. Perit Dial Int 2006; 26:559-63.
9. Oules R, Challah S, Brunner FP. Case-control study to determine the cause of sclerosing peritoneal disease. Nephrol Dial Transplant 1988; 3:66-9.
10. Kolesnyk I, Dekker FW, Noordzij M, le Cessie S, Struijk DG, Krediet RT. Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients. Perit Dial Int 2007; 27:446-53.
11. Kolesnyk I, Noordzij M, Dekker FW, Boeschoten EW, Krediet RT. A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients. Nephrol Dial Transplant 2009; 24:272-7.